Jens Gertow

Holds a PhD in transplantation immunology from the Karolinska Institute. Thinks cell therapy is the best thing since sliced bread. Joined Mabtech in 2015 and was appointed CCO in 2018.

Jens’s recommended reads

Highlighted research, Published February 23, 2024

Immunoassays for immunotherapy research

Explore the critical role of ELISpot and FluoroSpot assays in immunotherapy and cell and gene therapy, empowering research and development with sensitive potency assays in line with FDA guidelines.

Tutorial, Published August 23, 2023

Why resting cells is essential for accurate ELISpot and FluoroSpot

Learn about the importance of resting cells before your next ELISpot or FluoroSpot.

Highlighted research, Published October 28, 2024

Immunoassays for infectious disease research

Explore the role of immunoassays like ELISpot and FluoroSpot in infectious disease research. Discover how Mabtech's immunoassays enable researchers to study immune responses at the cellular level for diseases like TB, SARS-CoV-2, Malaria, HIV, and more.

Tutorial, Published November 24, 2022

Cell stimulation in ELISpot and FluoroSpot

In this feature, we’ll walk you through the optimal use of different polyclonal and antigen-specific stimuli.

Technote, Published November 21, 2023

Technote: Whole Blood ELISpot

Learn how our R&D team developed and optimized a new protocol for using whole blood in the ELISpot assay.

More about Jens

Job title

Chief Commercial Officer

jens.gertow@mabtech.com